This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
mtaschetta-millane Wed, 07/10/2024 - 09:02 July 10, 2024 — CellProthera , a private company specializing in cell-based therapies for repairing ischemic tissues, and BioCardia, Inc. ,
Two researchers independently screened, extracted data, and assessed quality using the Newcastle-Ottawa Scale (NOS) and Revman5.3. Meta-analysis with Stata 16.0 calculated the combined Odd ratio (OR) for WHR and MI risk.
Nature Reviews Cardiology, Published online: 03 May 2024; doi:10.1038/s41569-024-01031-z In the AEGIS-II trial, infusion of apolipoprotein A-I to increase cholesterol efflux capacity did not improve outcomes in patients with acute myocardialinfarction.
A 69-year-old man with a history of MI and cardiomyopathy presented with 2 days of dyspnea. Regular tachycardia (124 beats per min), diaphoresis, and rales were present. A diagnosis was made.
This case report describes a unique instance of a patient developing AEF following AF ablation, accompanied by ischemic stroke and myocardialinfarction. A 71-year-old male admitted to the emergency department on July 19, 2024, with acute loss of consciousness and convulsions.
The Hidden Threat: SMuRFless MyocardialInfarctions A concerning trend in CVD is the increase in myocardialinfarctions (MI) among individuals without standard modifiable risk factors (SMuRFless MI). Mortality is higher within 30 days of the event, as demonstrated in survival analyses from the SWEDEHEART registry.
Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.
More than half of the patients presented with heart failure (n=2,234, 55.4%), followed by acute myocardialinfarction (n=1,368, 34.0%), coronary artery disease (n=674, 16.7%), and acute coronary syndrome (n=164, 4.1%). The mean age ranged between 56 and 76 and 5873 years for depressed vs. non-depressed individuals respectively.
The benefits of complete revascularization over culprit-only coronary artery revascularization were confirmed in older patients with ST-segment elevation myocardialinfarction (STEMI) and multivessel disease over the first 4 years, according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.
Myocardial remodeling is characterized by gradual heart enlargement, cardiac dysfunction, and extraordinary molecular changes. Cardiac remodeling after myocardialinfarction is almost inevitable, which is the leading cause of heart failure. Autophagy has a protective effect on myocardial remodeling improvement.
An invasive strategy vs. optimal medical therapy alone after a non-ST-elevation myocardialinfarction (NSTEMI) in older adults did not affect the combined risk of cardiovascular death or MI, although non-fatal MIs and subsequent revascularization procedures were reduced, according to late-breaking research presented in a Hot Line session Sept.
Circulation, Volume 150, Issue Suppl_1 , Page A4141714-A4141714, November 12, 2024. Background:Myocardial infarction is a leading cause of morbidity and mortality worldwide, often resulting in extensive myocardial cell death and the release of damage-associated molecular patterns.
Publication date: Available online 23 July 2024 Source: The American Journal of Cardiology Author(s): Kahtan Fadah, Helayna Abraham, Subhash Banerjee, Debabrata Mukherjee
The American College of Cardiology (ACC) held its 73 rd annual scientific session and expo April 6-8, 2024 in Atlanta, Georgia. EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardialinfarction (MI). April 6, 2024. April 7, 2024. April 7, 2024.
Int J Cardiol 2024 2. ST depression in lead AVL differentiates inferior ST-elevation myocardialinfarction from pericarditis. Ischemic ST-segment depression maximal in V1-4 (versus V5-6) of any amplitude is specific for occlusion myocardialinfarction (versus nonocclusive ischemia). De Alencar Neto. Nikus et al.
Publication date: Available online 20 May 2024 Source: The American Journal of Cardiology Author(s): Marsioleda Kemberi, Eduardo Urgesi, Ji ngYong Ng, Kush Patel, Mohammed Y Khanji, Wael I Awad
Circulation, Volume 150, Issue Suppl_1 , Page A4146832-A4146832, November 12, 2024. Introduction:After a myocardialinfarction (MI), cardiac fibroblasts are activated to deposit extracellular matrix that while prevents acute cardiac rupture in the short-term, causes long-term diastolic and systolic dysfunction.
Compared with: 8/18/2024 6:08 AM This time neither see acute MI. But the Queen of Hearts now sees it: Notice that the dark blue in this explainability map tells you that she also is seeing the short S-wave and the hyperacute T-wave!
The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. The NUDGE-FLU trial revealed cardiovascular-focused messaging increased flu vaccination rates in myocardialinfarction patients. Co-chaired by leading experts Peter Libby, MD , Erin D.
Higher risk of myocardialinfarction, heart failure and atrial fibrillation was noted in spinal cord injury survivors compared to controls. Increased Risk of MyocardialInfarction, Heart Failure, and Atrial Fibrillation After Spinal Cord Injury. 2024 Feb 20;83(7):741-751. Am J Phys Med Rehabil. doi: 10.1097/PHM.0b013e31802f0247.
Publication date: 15 January 2024 Source: The American Journal of Cardiology, Volume 211 Author(s): Gema Miñana, Alberto Cordero, Lorenzo Fácila, Mireia Company, Agustín Fernández-Cisnal, Ernesto Valero, Arturo Carratalá, Jorge Navarro, Javier Torres Llergo, Rosa Fernández-Olmo, Almudena Castro, Vicent Bodi, Juan Sanchis, Julio Núñez
Publication date: Available online 7 September 2024 Source: The American Journal of Cardiology Author(s): Khawaja M. Talha, Kendall Hammonds, Ayman Alhamdow, Monica M. Bennett, J. Vee Anne Bomar, Jason A. Ettlinger, Monica Martinez-Traba, Elisabeth Sophia Hartgers-Gubbels, Elisa L. Priest, Courtney N. Shaver, Aasim Afzal, Robert J.
Circulation, Volume 150, Issue Suppl_1 , Page A4141170-A4141170, November 12, 2024. In cardiovascular research, serotonin has been implicated in modulating vascular tone, platelet aggregation, and myocardial function. years, 53 women) followed for up to 15 years.
Circulation, Volume 150, Issue Suppl_1 , Page A4121215-A4121215, November 12, 2024. Heterogeneity was examined with I2statistics.Results:We included 12 RCT articles consisting of 23,178 patients that received empagliflozin after acute myocardialinfarction were considered.
Circulation, Volume 150, Issue Suppl_1 , Page A4135252-A4135252, November 12, 2024. Background:Pulmonary hypertension (PH) is a major contributor to cardiovascular disease-related morbidity and mortality.
In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 European Society of Cardiology annual meeting.
Abstract Aims Patients with a reduced left ventricular ejection fraction (LVEF) following an acute myocardialinfarction (MI) are considered to be at risk of progressive adverse cardiac remodelling which can lead to the development of heart failure and death. From October 2022 to January 2024, 105 eligible patients were randomized.
Patients were evaluated based on a composite outcome of all-cause mortality, stroke, or myocardialinfarction. European Heart Journal (2024) 00, 1–9. The study, spanning a decade, enrolled 280 patients, randomly assigned to either TAVI with the CoreValve bioprosthesis or SAVR. Original article: Thyregod HGH et al.
mtaschetta-millane Wed, 07/17/2024 - 11:06 July 17, 2024 — BioCardia, Inc. , This design is intended to enable smooth navigation and prevent “whip,” when the build-up of mechanical forces in the device causes a catheter to suddenly jump from one orientation to another. This is an elegant solution to a long-standing technical issue.
Stroke, Volume 55, Issue Suppl_1 , Page AWMP98-AWMP98, February 1, 2024. Cases with a positive cTN underwent retrospective review by cardiologists using the Fourth Universal Definition of MyocardialInfarction (MI). Whether this association depends on the cause of the cTn elevation is unclear.
In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions.
Thus, it has recently become generally accepted that most plaque ruptures resulting in myocardialinfarction occur in plaques that narrow the lumen diameter by 40% of the arterial cross section may be involved by plaque. This confirms that the pain was ischemia and is now resovled. The i nitial hs troponin I returned 75%.
milla1cf Sat, 04/06/2024 - 18:32 April 6, 2024 — The first trial of a novel strategy for removing cholesterol from patients’ arteries did not reduce the risk of death, heart attack or stroke within three months of a prior heart attack, according to research presented at the American College of Cardiology ’s Annual Scientific Session.
Publication date: Available online 24 February 2024 Source: The American Journal of Cardiology Author(s): Yousaf Abughofah, Wesley Anderson, Rolf P Kreutz
2024, [link]. 1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years. Journal of Vascular Surgery, Mar.
Circulation, Volume 150, Issue Suppl_1 , Page A4139191-A4139191, November 12, 2024. These challenges highlight the need for new therapies that are both safe and effective in targeting the structural remodeling pivotal to disease progression post-myocardialinfarction (MI).
Publication date: Available online 11 September 2024 Source: The American Journal of Cardiology Author(s): Christos Gogos, Vasileios Anastasiou, Andreas S.
Nature Reviews Cardiology, Published online: 02 April 2024; doi:10.1038/s41569-024-01022-0 After myocardialinfarction, the heart secretes small extracellular vesicles with pro-neoplastic properties that can accelerate tumour growth when taken up by cancer cells.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content